| Literature DB >> 27351335 |
Tyler D Huber1,2, Fengbin Wang3, Shanteri Singh1,2, Brooke R Johnson1,2, Jianjun Zhang1,2, Manjula Sunkara4, Steven G Van Lanen2, Andrew J Morris4, George N Phillips3,5, Jon S Thorson1,2.
Abstract
S-adenosyl-l-methionine (AdoMet) is an essential enzyme cosubstrate in fundamental biology with an expanding range of biocatalytic and therapeutic applications. We report the design, synthesis, and evaluation of stable, functional AdoMet isosteres that are resistant to the primary contributors to AdoMet degradation (depurination, intramolecular cyclization, and sulfonium epimerization). Corresponding biochemical and structural studies demonstrate the AdoMet surrogates to serve as competent enzyme cosubstrates and to bind a prototypical class I model methyltransferase (DnrK) in a manner nearly identical to AdoMet. Given this conservation in function and molecular recognition, the isosteres presented are anticipated to serve as useful surrogates in other AdoMet-dependent processes and may also be resistant to, and/or potentially even inhibit, other therapeutically relevant AdoMet-dependent metabolic transformations (such as the validated drug target AdoMet decarboxylase). This work also highlights the ability of the prototypical class I model methyltransferase DnrK to accept non-native surrogate acceptors as an enabling feature of a new high-throughput methyltransferase assay.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27351335 PMCID: PMC5026608 DOI: 10.1021/acschembio.6b00348
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100